Over the past four years, one question has repeatedly surfaced within the UK hemp and CBD industry: how did certain CBD products, including those linked to Pureis, come to be included on the Food Standards Agency CBD Public List despite clear requirements that products had to be on the market before 13 February 2020? This article examines the evidence, correspondence, FOI disclosures, and complaint files surrounding that question.

When a fixed regulatory deadline meets withheld evidence and shifting interpretations, questions follow. This open letter examines how the UK Food Standards Agency has applied its CBD novel foods rules—and whether those decisions can be properly scrutinised.

There is every reason why the ACNFP should not be happy with RP427 The main issue is that the application itself is specifically for 10% CB

0.69% of the Novel Foods list is validated, yet just under half of them shouldn't be.